Canada markets open in 31 minutes

Statera Biopharma, Inc. (STAB)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00070.0000 (0.00%)
At close: 12:52PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 49.99k
Enterprise Value 6.95M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.16
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.37

Trading Information

Stock Price History

Beta (5Y Monthly) 281.36
52-Week Change 3-96.67%
S&P500 52-Week Change 322.43%
52 Week High 30.0380
52 Week Low 30.0001
50-Day Moving Average 30.0006
200-Day Moving Average 30.0007

Share Statistics

Avg Vol (3 month) 325.08k
Avg Vol (10 day) 36.47k
Shares Outstanding 571.42M
Implied Shares Outstanding 671.42M
Float 848.11M
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short (Dec 30, 2022) 4774.53k
Short Ratio (Dec 30, 2022) 40.39
Short % of Float (Dec 30, 2022) 41.65%
Short % of Shares Outstanding (Dec 30, 2022) 41.42%
Shares Short (prior month Nov 30, 2022) 4829.13k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Sept 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-230.65%

Management Effectiveness

Return on Assets (ttm)-23.85%
Return on Equity (ttm)-286.94%

Income Statement

Revenue (ttm)3.69M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)183.50%
Gross Profit (ttm)N/A
EBITDA -20.58M
Net Income Avi to Common (ttm)-91.83M
Diluted EPS (ttm)-2.3600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)506.1k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)7.41M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.05
Book Value Per Share (mrq)-0.20

Cash Flow Statement

Operating Cash Flow (ttm)-12.09M
Levered Free Cash Flow (ttm)340.1k